Prevalence of nandrolone preparations with endogenous carbon isotope ratios in Australia

IF 2.6 3区 医学 Q2 BIOCHEMICAL RESEARCH METHODS
Michael Polet, Peter Van Eenoo, Lance Brooker, Claire Edey, Vanessa Agon, Janelle Grainger, Gemma Payne, Catrin Goebel
{"title":"Prevalence of nandrolone preparations with endogenous carbon isotope ratios in Australia","authors":"Michael Polet,&nbsp;Peter Van Eenoo,&nbsp;Lance Brooker,&nbsp;Claire Edey,&nbsp;Vanessa Agon,&nbsp;Janelle Grainger,&nbsp;Gemma Payne,&nbsp;Catrin Goebel","doi":"10.1002/dta.3654","DOIUrl":null,"url":null,"abstract":"<p>Nandrolone and its prohormones, including 19-norandrost-4-ene-3,17-dione and 19-norandrost-4-ene-3β,17β-diol, are anabolic steroids forbidden at all times in sports according to the World Anti<span>-</span>Doping Code Prohibited List and its metabolite 19-norandrosterone (19NA) is the preferred urinary target compound to identify their abuse. In recent years, an increasing number of 19NA isotope ratio mass spectrometry (IRMS) cases have arisen that, based on the initial testing procedure, were likely to result in an adverse analytical finding but were concluded negative after IRMS analysis. The current study was therefore set up to gain a better insight on the prevalence of nandrolone preparations with endogenous carbon isotope ratio values in Australia. Suitable workplace (non-athlete) urine samples that had previously been reported positive for 19NA were identified and analysed on IRMS. A total of 82% of the samples that were analysed were reported with enriched carbon isotope ratios of 19NA (i.e., 19NA greater than −26‰). This indicates that there is a high prevalence of nandrolone-containing anabolic androgenic steroid preparations in Australia that have ‘endogenous’ carbon isotope ratios which reduces the ability to identify exogenous nandrolone.</p>","PeriodicalId":160,"journal":{"name":"Drug Testing and Analysis","volume":"16 11","pages":"1345-1349"},"PeriodicalIF":2.6000,"publicationDate":"2024-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Testing and Analysis","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/dta.3654","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0

Abstract

Nandrolone and its prohormones, including 19-norandrost-4-ene-3,17-dione and 19-norandrost-4-ene-3β,17β-diol, are anabolic steroids forbidden at all times in sports according to the World Anti-Doping Code Prohibited List and its metabolite 19-norandrosterone (19NA) is the preferred urinary target compound to identify their abuse. In recent years, an increasing number of 19NA isotope ratio mass spectrometry (IRMS) cases have arisen that, based on the initial testing procedure, were likely to result in an adverse analytical finding but were concluded negative after IRMS analysis. The current study was therefore set up to gain a better insight on the prevalence of nandrolone preparations with endogenous carbon isotope ratio values in Australia. Suitable workplace (non-athlete) urine samples that had previously been reported positive for 19NA were identified and analysed on IRMS. A total of 82% of the samples that were analysed were reported with enriched carbon isotope ratios of 19NA (i.e., 19NA greater than −26‰). This indicates that there is a high prevalence of nandrolone-containing anabolic androgenic steroid preparations in Australia that have ‘endogenous’ carbon isotope ratios which reduces the ability to identify exogenous nandrolone.

Abstract Image

澳大利亚具有内源性碳同位素比率的诺龙制剂的流行情况。
根据《世界反兴奋剂条例禁用清单》,诺龙及其前体(包括 19-去甲雄甾-4-烯-3,17-二酮和 19-去甲雄甾-4-烯-3β,17β-二醇)是任何时候都禁止在体育运动中使用的合成代谢类固醇,其代谢物 19-去甲雄酮(19NA)是识别其滥用的首选尿液目标化合物。近年来,出现了越来越多的 19NA 同位素比质谱(IRMS)病例,根据最初的检测程序,这些病例很可能会得出不利的分析结果,但经过 IRMS 分析后却得出了阴性结论。因此,本研究旨在更好地了解澳大利亚具有内源性碳同位素比值的诺龙制剂的流行情况。研究人员确定了合适的工作场所(非运动员)尿样,这些尿样之前曾报告 19NA 呈阳性,并在 IRMS 系统上进行了分析。在分析的样本中,共有 82% 的样本报告 19NA 的碳同位素比值富集(即 19NA 大于 -26‰)。这表明,在澳大利亚,含有诺龙的合成代谢雄性类固醇制剂非常普遍,这些制剂具有 "内源性 "碳同位素比率,从而降低了识别外源性诺龙的能力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Drug Testing and Analysis
Drug Testing and Analysis BIOCHEMICAL RESEARCH METHODS-CHEMISTRY, ANALYTICAL
CiteScore
5.90
自引率
24.10%
发文量
191
审稿时长
2.3 months
期刊介绍: As the incidence of drugs escalates in 21st century living, their detection and analysis have become increasingly important. Sport, the workplace, crime investigation, homeland security, the pharmaceutical industry and the environment are just some of the high profile arenas in which analytical testing has provided an important investigative tool for uncovering the presence of extraneous substances. In addition to the usual publishing fare of primary research articles, case reports and letters, Drug Testing and Analysis offers a unique combination of; ‘How to’ material such as ‘Tutorials’ and ‘Reviews’, Speculative pieces (‘Commentaries’ and ‘Perspectives'', providing a broader scientific and social context to the aspects of analytical testing), ‘Annual banned substance reviews’ (delivering a critical evaluation of the methods used in the characterization of established and newly outlawed compounds). Rather than focus on the application of a single technique, Drug Testing and Analysis employs a unique multidisciplinary approach to the field of controversial compound determination. Papers discussing chromatography, mass spectrometry, immunological approaches, 1D/2D gel electrophoresis, to name just a few select methods, are welcomed where their application is related to any of the six key topics listed below.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信